Lindbrook Capital »

Regeneron Pharmaceuticals shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 1.1k 1051.24
2024-06-30 $1.2M 1.2k 1051.03
2024-03-31 $1.1M 1.1k 962.49
2023-12-31 $970k 1.1k 878.29
2023-09-30 $848k 1.0k 822.96
2023-06-30 $714k 993 718.54
2023-03-31 $855k 1.0k 821.67
2022-12-31 $694k 962 721.49
2022-09-30 $639k 928 688.58
2022-06-30 $528k 894 590.60
2022-03-31 $636k 911 698.13
2021-12-31 $567k 898 631.40
2021-09-30 $544k 899 605.12
2021-06-30 $498k 891 558.92
2021-03-31 $397k 840 472.62
2020-12-31 $425k 879 483.50
2020-09-30 $463k 828 559.18
2020-06-30 $544k 873 623.14
2020-03-31 $421k 862 488.40
2019-12-31 $325k 865 375.72
2019-09-30 $239k 860 277.91
2019-06-30 $247k 792 311.87
2019-03-31 $344k 840 409.52
2018-12-31 $313k 840 372.62